Search bioRxiv⌕ Search

Biology subjects

Accolla, R. P.

Publications and source records attributed to Accolla, R. P..

2 recordsLinked to original sources

Optimizing 3D-printed Scaffold Geometry Decreases Foreign Body Response and Enhances Allogeneic Islet Transplant Outcomes

Cellular therapy, such as beta cell transplantation for Type 1 diabetes, is a promising approach to durably alleviate disease states. Implanting cells within porous scaffolds is beneficial as they distribute the cells and mechanically support implantation; however, scaffolds can exacerbate foreign body responses (FBR). While the geometric features of a scaffold are known to impact FBR, there is limited consensus on what makes an ideal implant. Some have explored the role of pore size and interconnectivity; however, the impact of rung thickness between pores on FBR is broadly understudied. To investigate this parameter, we created a scaffold with reproducible geometric features and high biostability by combining 3D-printing with the polymer polydimethylsiloxane (PDMS). We tested 3D-printed scaffold prototypes with identical pore sizes but distinct PDMS rung thicknesses ranging from 150 to 300 {micro}m. Upon transplantation, biocompatibility screening in a mouse model revealed that scaffolds with thicker PDMS rungs led to increased intra-device fibrosis. Additional spatio-proteomic analysis revealed distinct differences in host responses to rung changes, with alterations in macrophage and adaptive immune cell markers, as well as fibrotic proteins, within scaffolds containing thicker rungs. Selecting the optimized rung size, we evaluated its efficacy in rat syngeneic and allogeneic islet transplant models. In the allogeneic model, 3D-printed scaffold islet implants demonstrated robust efficacy and stability, yielding improved outcomes compared to PDMS scaffolds without optimized geometric features. Results from this study reveal how specific geometric scaffold features critically influence FBR to biomaterial implants, accelerating or mitigating fibrotic responses, and ultimately determining transplant success.

bioengineering↗

Controlled Release of Anti-inflammatory and Pro-angiogenic Factors from Macroporous Scaffolds

The simultaneous local delivery of anti-inflammatory and pro-angiogenic agents via biomaterial scaffolds presents a promising method for improving the engraftment of tissue-engineered implants while avoiding potentially detrimental systemic delivery. In this study, PDMS microbeads were loaded with either anti-inflammatory dexamethasone (Dex) or pro-angiogenic 17{beta}-estradiol (E2) and subsequently integrated into a single macroporous scaffold to create a controlled, dual drug-delivery platform. Compared to a standard monolithic drug dispersion scaffold, macroporous scaffolds containing drug-loaded microbeads exhibited reduced initial burst release and increased the durability of drug release for both agents. Incubation of scaffolds with LPS-stimulated M1 macrophages found that Dex suppressed the production of pro-inflammatory and pro-angiogenic factors, when compared to drug-free control scaffolds; however, the co-incubation of macrophages with Dex and E2 scaffolds restored their pro-angiogenic features. Following implantation, Dex-loaded microbead scaffolds (Dex-{micro}BS) suppressed host cell infiltration and integration, when compared to controls. In contrast, the co-delivery of dexamethasone with estrogen from the microbead scaffold (Dex/E2-{micro}BS) dampened overall host cell infiltration but restored graft vascularization. These results demonstrate the utility of a microbead scaffold approach for the controlled, tailored, and local release of multiple drugs from an open framework implant. It further highlights the complementary impacts of local Dex and E2 delivery to direct the healthy integration of implants, which has broad applications to the field of tissue engineering and regenerative medicine.

bioengineering↗